Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Marker Therapeutics Q2 EPS $(0.13) Up From $(0.14) YoY

Marker Therapeutics (NASDAQ:MRKR) reported quarterly losses of $(0.13) per share. This is a 7.14 percent increase over losses of $(0.14) per share from the same period last year.
byBenzinga Newsdesk
August 10, 2021
1 minute read
Total
0
Shares
0
0
0
0
0
0

Marker Therapeutics (NASDAQ:MRKR) reported quarterly losses of $(0.13) per share. This is a 7.14 percent increase over losses of $(0.14) per share from the same period last year.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts